Bio-Rad Laboratories, Inc. (BIO.B)

NYSE: BIO.B · Real-Time Price · USD

268.50

-13.45 (-4.77%)

At close: Mar 9, 2026, 4:00 PM EDT

268.50

0.00 (0.00%)

After-hours: Mar 9, 2026, 4:10 PM EDT

Bio-Rad Laboratories Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	2,583	2,567	2,671	2,802	2,923
Revenue Growth (YoY)	0.65%	-3.92%	-4.67%	-4.12%	14.81%
Cost of Revenue	1,243	1,188	1,244	1,235	1,284
Gross Profit	1,340	1,379	1,427	1,567	1,638
Selling, General & Admin	844.3	814	841.7	827.8	877.12
Research & Development	275.6	295.9	247.4	256.9	260.64
Other Operating Expenses	172.8	-	-	-	-
Total Operating Expenses	1,293	1,110	1,089	1,085	1,138
Operating Income	47.2	269	337.8	482.6	500.34
Interest Expense	-49	-48.9	-49.4	-38.1	-1.55
Other Non-Operating Income (Expense)	-803.5	2,751	1,366	5,239	-4,902
Total Non-Operating Income (Expense)	-852.5	2,702	1,317	5,200	-4,904
Pretax Income	995.5	-2,343	-850.1	-4,704	5,449
Provision for Income Taxes	-235.6	498.3	212.8	1,077	-1,195
Net Income	759.9	-1,844	-637.3	-3,628	4,254
Net Income to Common	759.9	-1,844	-637.3	-3,628	4,254
Net Income Growth	-	-	-	-	11.54%
Shares Outstanding (Basic)	27	28	29	30	30
Shares Outstanding (Diluted)	27	28	29	30	30
Shares Change (YoY)	-3.31%	-3.41%	-1.93%	-1.40%	0.16%
EPS (Basic)	27.87	-65.36	-21.82	-121.79	142.61
EPS (Diluted)	27.85	-65.36	-21.82	-121.79	140.83
EPS Growth	-	-	-	-	11.35%
Free Cash Flow	906.8	744.8	593.1	81.6	535.72
Free Cash Flow Growth	21.75%	25.58%	626.84%	-84.77%	12.45%
Free Cash Flow Per Share	33.24	26.40	20.31	2.74	17.73
Gross Margin	51.87%	53.73%	53.42%	55.93%	56.05%
Operating Margin	1.83%	10.48%	12.65%	17.22%	17.12%
Profit Margin	29.42%	-71.86%	-23.86%	-129.45%	145.57%
FCF Margin	35.10%	29.02%	22.20%	2.91%	18.33%
EBITDA	212.6	420.6	483.7	482.6	500.34
EBITDA Margin	8.23%	16.39%	18.11%	17.22%	17.12%
EBIT	47.2	269	337.8	482.6	500.34
EBIT Margin	1.83%	10.48%	12.65%	17.22%	17.12%
Effective Tax Rate	-23.67%	-21.27%	-25.03%	-22.89%	-21.93%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q